CORAL GABLES, FL / ACCESSWIRE / February 12, 2019 / The strength of the healthcare stock market is largely dependent on the fact that, as the global population increases, so too does the need for greater access to healthcare. Companies working in the healthcare sector are tasked with meeting the growing demand for effective treatment options given that, almost every day, medical experts discover a new disease or ailment. As these companies work to develop new methods for bettering the care provided to their patients, the industry, in its entirety, may see more investors flocking towards the sector, in search of potential opportunities. Premier Health Group (OTC:PHGRF) (CSE:PHGI), CAS Medical Systems Inc (CASM), CorMedix Inc (NYSE American: CRMD), and Viking Therapeutics Inc (VKTX) represent four healthcare companies determined to create products to help consumers have a better life.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies used throughout the healthcare industry to create the best-possible care solutions for their growing patient network. In an industry where companies are constantly trying to rise to the challenge of new diseases, Premier is primed to overcome any obstacle in their path.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced towards the end of last week that the Company is now formally entering the cannabis clinic space. Premier's recent acquisition of Cloud Practice Inc has provided an underlying platform to help empower and streamline patient-doctor interaction. Whereas other clinics typically struggle with the labor-intensive process of onboarding patients, this will be done automatically with Premier's smart EMR.
Premier Health Group (OTC:PHGRF) (CSE:PHGI)'s integrated technology will assess the patient's data, and through the use of analytics, output a comprehensive recommendation along with links to corresponding research relevant to the diagnosis. The only responsibility of the healthcare professional is that they must simply determine which patient could best be served by using medical cannabis products.
Dr. Essam Hamza, CEO of Premier Health Group (OTC:PHGRF) (CSE:PHGI), commented, "We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR). There has been a critical gap between the patient's need for medical cannabis and the doctor's knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem."
CAS Medical Systems (CASM) today announced that it has entered into a definitive merger agreement to be acquired by Edwards Lifesciences Corporation, a company leading the industry in patient-focused innovations for structural heart disease. Per the details of the agreement, Edwards will acquire CAS Medical in an all-cash transaction for $2.45 per share of Common Stock, or an equity value of approximately $100 million.
Thomas Patton, president, and CEO of
CorMedix Inc (CRMD) enjoyed impressive gains in the market on Tuesday, with shares up 8.45%, trading at just above $2.30 per share. In late-January, the Company announced the topline results of the full data set of the Company's Phase 3 LOCK-IT-100 study for Neutrolin® as a catheter lock solution in hemodialysis patients.
According to the results, There was a 71% reduction in the risk of occurrence of CRBSIs compared with the active control of heparin, which is well in excess of the study's assumed treatment effect size of a 55% reduction.
Viking Therapeutics Inc (VKTX) had a banner day in the market on Tuesday as its shares rose 10.42% in the late-afternoon, trading at $8.95 per share. In early January, the clinical-stage biopharmaceutical company, which focuses on developing therapies for metabolic and endocrine disorders, announced that its chief executive officer, Brian Lian, would deliver a corporate presentation at the 11th Annual Biotech Showcase™ later in the month.
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
View source version on accesswire.com: